Manske Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$658K Sell
549
-56
-9% -$57.2K 0.16% 113
2026
Q1
$556K Buy
605
+129
+27% +$131K 0.16% 111
2025
Q4
$512K Buy
476
+28
+6% +$26.8K 0.15% 113
2025
Q3
$342K Buy
448
+11
+3% +$8.19K 0.1% 143
2025
Q2
$341K Buy
+437
New +$340K 0.11% 134

Other funds holding LLY

Manske Wealth Management's LLY Position: Q2 2026 in Review

Manske Wealth Management reduced its Eli Lilly (LLY) stake by 9.3% in Q2 2026, selling an estimated $57.2K and leaving 549 shares worth $658K. The position accounts for 0.16% of the portfolio, ranked #113.

Manske Wealth Management first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Manske Wealth Management held 549 shares of Eli Lilly worth $658K as of Q2 2026.
  • Manske Wealth Management sold 56 Eli Lilly shares in Q2 2026, an estimated $57.2K.
  • Eli Lilly made up 0.16% of Manske Wealth Management's portfolio in Q2 2026, its #113 holding.
  • Manske Wealth Management first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Manske Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.